CXORF38 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.047610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.608600E-01
Normal-vs-Stage2
5.000000E-01
Normal-vs-Stage3
1.226430E-01
Normal-vs-Stage4
4.742800E-01
Stage1-vs-Stage2
5.169800E-01
Stage1-vs-Stage3
1.595430E-01
Stage1-vs-Stage4
6.072000E-01
Stage2-vs-Stage3
6.103800E-02
Stage2-vs-Stage4
8.986800E-01
Stage3-vs-Stage4
3.050200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.133640E-01
Normal-vs-AfricanAmerican
2.228000E-01
Normal-vs-Asian
2.076800E-01
Caucasian-vs-AfricanAmerican
7.222400E-01
Caucasian-vs-Asian
8.762000E-01
AfricanAmerican-vs-Asian
6.263000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.220200E-02
Normal-vs-Female
1.831440E-01
Male-vs-Female
7.544400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.327000E-01
Normal-vs-Age(41-60Yrs)
2.594000E-01
Normal-vs-Age(61-80Yrs)
7.784400E-02
Normal-vs-Age(81-100Yrs)
4.524600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.644800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.459400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.076800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.130100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.992600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.151200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.162600E-01
Normal-vs-Daily Drinker
3.324000E-01
Normal-vs-Weekly Drinker
1.531400E-01
Normal-vs-Occasional Drinker
2.782200E-01
Normal-vs-Social Drinker
4.879000E-01
Non Drinker-vs-Daily Drinker
4.418600E-01
Non Drinker-vs-Weekly Drinker
7.182400E-01
Non Drinker-vs-Occasional Drinker
3.700200E-01
Non Drinker-vs-Social Drinker
6.451000E-01
Daily Drinker-vs-Weekly Drinker
3.790600E-01
Daily Drinker-vs-Occasional Drinker
9.439800E-01
Daily Drinker-vs-Social Drinker
7.391000E-01
Weekly Drinker-vs-Occasional Drinker
3.002200E-01
Weekly Drinker-vs-Social Drinker
4.617800E-01
Occasional Drinker-vs-Social Drinker
6.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.574800E-01
Normal-vs-Grade 2
2.948300E-02
Normal-vs-Grade 3
9.304100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.795100E-03
Grade 1-vs-Grade 3
3.154900E-04
Grade 1-vs-Grade 4
2.574800E-01
Grade 2-vs-Grade 3
1.468190E-01
Grade 2-vs-Grade 4
2.948300E-02
Grade 3-vs-Grade 4
9.304100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.673800E-02
Normal-vs-NonDiabetic
8.740200E-02
Diabetic-vs-NonDiabetic
6.647000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.711400E-01
Normal-vs-NoPancreatitis
7.656100E-02
Pancreatitis-vs-NoPancreatitis
1.337770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.034300E-02
Normal-vs-N1
1.344000E-01
N0-vs-N1
2.356200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.717400E-01
Normal-vs-TP53-NonMutant
1.005640E-01
TP53-Mutant-vs-TP53-NonMutant
1.218120E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
